These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 3877117)

  • 1. Enzyme-linked immunosorbent assay to monitor colorectal carcinoma patients treated with a monoclonal antibody (17-1A).
    Curtet C; Maurel C; Douillard JY; Le Mevel B; Kremer M; Sai P; Chatal JF
    J Immunol Methods; 1985 Oct; 83(1):193-9. PubMed ID: 3877117
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-idiotypic antibodies to monoclonal antibody CO17-1A.
    Herlyn D; Sears H; Iliopoulos D; Lubeck M; Douillard JY; Sindelar W; Tempero M; Mellstedt H; Maher M; Koprowski H
    Hybridoma; 1986 Jul; 5 Suppl 1():S51-8. PubMed ID: 3488951
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-idiotype immunization of cancer patients: modulation of the immune response.
    Herlyn D; Wettendorff M; Schmoll E; Iliopoulos D; Schedel I; Dreikhausen U; Raab R; Ross AH; Jaksche H; Scriba M
    Proc Natl Acad Sci U S A; 1987 Nov; 84(22):8055-9. PubMed ID: 3500471
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patients treated with a monoclonal antibody (ab1) to the colorectal carcinoma antigen 17-1A develop a cellular response (DTH) to the "internal image of the antigen" (ab2).
    Mellstedt H; Frödin JE; Biberfeld P; Fagerberg J; Giscombe R; Hernandez A; Masucci G; Li SL; Steinitz M
    Int J Cancer; 1991 May; 48(3):344-9. PubMed ID: 2040527
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Natural killer (NK) cell function is a strong prognostic factor in colorectal carcinoma patients treated with the monoclonal antibody 17-1A.
    Liljefors M; Nilsson B; Hjelm Skog AL; Ragnhammar P; Mellstedt H; Frödin JE
    Int J Cancer; 2003 Jul; 105(5):717-23. PubMed ID: 12740924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Specific detection of antibodies in cancer patients following immunotherapy with anti-idiotype.
    Wettendorff M; Iliopoulos D; Schmoll E; Koprowski H; Herlyn D
    J Immunol Methods; 1989 Jan; 116(1):105-15. PubMed ID: 2783712
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical status of monoclonal antibodies in the treatment of colorectal carcinoma.
    Mellstedt H; Frodin JE; Masucci G
    Oncology (Williston Park); 1989 Dec; 3(12):25-32; discussion 37-9, 42. PubMed ID: 2701408
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of growth of colorectal carcinoma in nude mice by monoclonal antibody.
    Herlyn DM; Steplewski Z; Herlyn MF; Koprowski H
    Cancer Res; 1980 Mar; 40(3):717-21. PubMed ID: 7471090
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Initial trial use of murine monoclonal antibodies as immunotherapeutic agents for gastrointestinal adenocarcinoma.
    Sears HF; Herlyn D; Steplewski Z; Koprowski H
    Hybridoma; 1986 Jul; 5 Suppl 1():S109-15. PubMed ID: 3488949
    [No Abstract]   [Full Text] [Related]  

  • 10. Detection of xenogeneic anti-idiotypic antibodies specific to murine monoclonal antibody 17-1A in patients with gastrointestinal cancer.
    Hanzawa Y; Tsujisaki M; Tokuchi S; Moriyama T; Izawa M; Imai K; Yachi A
    Tumour Biol; 1992; 13(4):226-36. PubMed ID: 1411140
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunotherapy of gastrointestinal cancer with monoclonal antibodies.
    Douillard JY; Le Mevel B; Curtet C; Vignoud J; Chatal JF; Koprowski H
    Med Oncol Tumor Pharmacother; 1986; 3(3-4):141-6. PubMed ID: 3468318
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human anti-idiotypic antibodies induced a humoral and cellular immune response against a colorectal carcinoma-associated antigen in patients.
    Fagerberg J; Steinitz M; Wigzell H; Askelöf P; Mellstedt H
    Proc Natl Acad Sci U S A; 1995 May; 92(11):4773-7. PubMed ID: 7539133
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Initial clinical evaluation of two murine IgG2a monoclonal antibodies for immunotherapy of gastrointestinal carcinoma.
    Herlyn D; Sears HF; Ernst CS; Iliopoulos D; Steplewski Z; Koprowski H
    Am J Clin Oncol; 1991 Oct; 14(5):371-8. PubMed ID: 1951172
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibody delivery and effector cell activation in a phase II trial of recombinant gamma-interferon and the murine monoclonal antibody CO17-1A in advanced colorectal carcinoma.
    Weiner LM; Moldofsky PJ; Gatenby RA; O'Dwyer J; O'Brien J; Litwin S; Comis RL
    Cancer Res; 1988 May; 48(9):2568-73. PubMed ID: 3128400
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Active specific immunotherapy with antiidiotypic antibodies in patients with solid tumors.
    O'Connell MJ; Chen ZJ; Yang H; Yamada M; Massaro M; Mittelman A; Ferrone S
    Semin Surg Oncol; 1989; 5(6):441-7. PubMed ID: 2688034
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Specific detection of anti-idiotypic immune responses in cancer patients treated with murine monoclonal antibody.
    Herlyn D; Lubeck M; Sears H; Koprowski H
    J Immunol Methods; 1985 Dec; 85(1):27-38. PubMed ID: 3878375
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical effects of monoclonal antibodies (MAb 17-1A) in patients with metastatic colorectal carcinomas.
    Frödin JE; Harmenberg U; Biberfeld P; Christensson B; Lefvert AK; Rieger A; Shetye J; Wahren B; Mellstedt H
    Hybridoma; 1988 Aug; 7(4):309-21. PubMed ID: 3262566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The human antimouse immunoglobulin response and the anti-idiotypic network have no influence on clinical outcome in patients with minimal residual colorectal cancer treated with monoclonal antibody CO17-1A.
    Gruber R; van Haarlem LJ; Warnaar SO; Holz E; Riethmüller G
    Cancer Res; 2000 Apr; 60(7):1921-6. PubMed ID: 10766181
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Measurement of IgG-blocking antibodies by ELISA using monoclonal antibody and fluorogenic substrate.
    Lee HB; Rommel F; Adkinson NF
    Int Arch Allergy Appl Immunol; 1988; 85(3):261-7. PubMed ID: 3258286
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell based radioimmunoassays to quantitate the immunoreactivity of TNT monoclonal antibodies directed against intracellular antigens.
    Gaffar SA; Chen FM; Liu C; Epstein AL
    J Immunoassay; 1991; 12(1):1-14. PubMed ID: 2040706
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.